Accepts Healthy Volunteers
Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms
An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.
An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.
Searching Both is inclusive of interventional and observational studies.
|Eligible Ages||18 Years and Over|
More Inclusion & Exclusion Criteria
Inclusion criteria for all participants: Healthy controls, PwMS (Persons with Multiple Sclerosis) and stroke patients.
- - Age > 18 years.
- - Able to understand and execute the test instructions.
- - Able to sit on a chair with low back support for 10 minutes.
- - Diagnosed with MS (Multiple Sclerosis) using McDonald criteria.
- - Able to move at least 1 out of 3 joints (wrist, elbow or shoulder): Medical Research Council score 3.
- - First- ever single, unilateral (ischemic or hemorrhagic) stroke.
- - No apraxia or hemi spatial neglect.
- - Able to move at least 1 out of 3 joints of the affected upper limb (wrist, elbow or shoulder): Medical Research Council score 3.
- - Other medical conditions interfering with the upper limb function or trunk (orthopedic or rheumatoid impairment) - Perceived pain in one of the upper limbs of more than 4/10 (Visual Analog Scale) - Severe cognitive or visual deficits interfering with testing.
This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.
Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.
Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.
Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.
Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.
The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.
The person who is responsible for the scientific and technical direction of the entire clinical study.
|Ilse Lamers, dr.|
|Principal Investigator Affiliation||Hasselt University|
Category of organization(s) involved as sponsor (and collaborator) supporting the trial.
The disease, disorder, syndrome, illness, or injury that is being studied.
|Multiple Sclerosis, Stroke|
Arms & Interventions
Experimental: persons with Multiple Sclerosis
Active Comparator: Healthy controls
Active Comparator: Stroke Patients
Other: - Clinical Scapular protocol (ClinScaP)
the psychometric properties of two tests: Clinical Scapular protocol (ClinScaP) in PwMS and healthy controls.
Other: - the prevalence of trunk, scapula and upper limb impairments.
To investigate the prevalence of trunk, scapula and upper limb impairments in PwMS and stroke patients.
Other: - the interaction between trunk, scapula and upper limb impairments.
To investigate the interaction between trunk, scapula and upper limb impairments in PwMS and stroke patients.
Contact a Trial Team
If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.